Executive Summary
The European Compounding Pharmacies Market is projected to display significant growth represented by a CAGR of 8.25% during 2023-2028. The European Compounding Pharmacies Market was valued at USD 3314.80 Million in the year 2021 with Italy holding the largest market share. In terms of segments, the availability of a diverse range of compounded formulas for dermatological purposes will drive segment expansion. Patients who are allergic to commercial pharmaceuticals might benefit from dermatology customised treatments.
The European Compounding Pharmacies market is a consolidated market. The major players in the market like Athenex, Baxter International, Fagron, Grifols, Capsa Healthcare, Nephron Pharmaceuticals, B. Braun, Fresenius, McKesson and Omnicell have a large geographical presence and a highly diversified product portfolio. These players focus on R&D, a large product portfolio, a wide geographical presence and an aggressive acquisition strategy.
Italy is holding the largest market share and is growing at the fastest rate during the forecast period, owing to the rising prevalence of therapeutic areas as well as the widespread use of pain management in developed countries like the United Kingdom and Germany.
The United Kingdom Compounding Pharmacies market has witnessed growth in recent years due to increased investments and offtake agreements among new companies to cope with new market strategies.
France is a lucrative market because of the presence of several compounding pharmacies, high adoption among people, and scarcity of many drugs, which are key factors for market growth.
Scope of the Report
• The report presents the analysis of the European Compounding Pharmacies Market for the historical period of 2018-2021, the estimated year 2022 and the forecast period of 2023-2028.
• The report analyses the Europe Compounding Pharmacies Market by Value (USD Million).
• The report analyses the Europe Compounding Pharmacies by Therapeutic Area (Hormone Replacement, Pain Management, Dermatology, and Other Sources).
• The report analyses the Europe Compounding Pharmacies Market), by End Users (Adult, Pediatric, Others, Geriatric, Veterinary).
• The report analyses the Europe Compounding Pharmacies Market by Type (Oral, Topical, Ophthalmic, Injectables, and Others Types).
• The Europe Compounding Pharmacies Market has been analysed by Country (United Kingdom, Germany, France, Italy, Spain, Russia, Turkey, Benelux, Nordic, and Rest of Europe).
• The key insights of the report have been presented through the leading company shares. Also, the attractiveness of the market has been presented by country, by Therapeutic Area, by End Users, by Type.
• Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
• The report tracks competitive developments, strategies, and recent developments. The companies analysed in the report include Athenex, Baxter International, Fagron, Grifols, Capsa Healthcare, Nephron Pharmaceuticals, B. Braun, Fresenius, McKesson and Omnicell.
Key Target Audience
• Healthcare and Pharmaceutical Companies
• End Users (Adult & Veterinary)
• Research and Development (R&D) Organizations
• Government Bodies & Regulating Authorities
• Investment Banks and Equity Firms
1. Introduction
1.1 Compounding Pharmacies Market Overview
1.2 Scope of Research
2. Executive Summary
2.1 Market Snapshot
2.2 Country Insights
2.3 Market Ecosystem Factors
3. Research Methodology
3.1 Data Collection Process
3.3 Market Size Calculation-Top-to-Bottom
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Analyst Recommendations
4.5 Trends
4.6 Impact Analysis
5. COVID-19 Impact Assessment
5.1 Degree of Impact of COVID-19 on Compounding Pharmacies Market
6. Porter's Five Forces analysis
7. Macro Economic Indicator Outlook
7.1 GDP per capita growth (USD)
7.2 Breakdown of Total Healthcare Expenditure (THE) in Europe - 2021
7.3Current Healthcare Expenditure
7.4 Pharmaceutical Spending/capita
8. Europe compounding Pharmacies Market
8.1 Impact Analysis of Macro Economic Factors on Compounding Pharmacies Market
8.2 Snapshot
8.3 Europe Compounding Pharmacies Market: Market Value Assessment
8.4 Market Summary
9. Europe Compounding Pharmacies Market Trend And Forecast Analysis, 2018-2028, By Therapeutic Area
9.1 Europe Compounding Pharmacies Market Trend And Forecast Analysis, Therapeutic Area: Snapshot
9.2 Hormone Replacement
9.3 Pain Management
9.4 Dermatology
9.5 Other Sources
10 Europe Compounding Pharmacies Market Trend And Forecast Analysis, 2018-2028, By End Users
10.1 Europe Compounding Pharmacies Market Trend And Forecast Analysis, End Users: Snapshot
10.2 Adult
10.3 Paediatric
10.4 Geriatric
10.5 Veterinary
11. Europe Compounding Pharmacies Market Trend And Forecast Analysis, 2018-2028, By Type
11.1 Europe Compounding Pharmacies Market Trend And Forecast Analysis, By Type: Snapshot
11.2 Oral
11.3 Topical
11.4 Ophthalmic
11.5 Injectables
11.6 Other Types
12. Europe Compounding Pharmacies Market Trend And Forecast Analysis, 2018-2028, By Country
12.1 United Kingdom Compounding Pharmacies Market Trend And Forecast Analysis: Segmentation
12.1.1 By Therapeutic Area
12.1.2 By End Users
12.1.3 By Type
12.2 Germany Compounding Pharmacies Market Trend And Forecast Analysis: Segmentation
12.2.1 By Therapeutic Area
12.2.2 By End Users
12.2.3 By Type
12.3 France Compounding Pharmacies Market Trend And Forecast Analysis: Segmentation
12.3.1 By Therapeutic Area
12.3.2 By End Users
12.3.3 By Type
12.4 Italy Compounding Pharmacies Market Trend And Forecast Analysis: Segmentation
12.4.1 By Therapeutic Area
12.4.2 By End Users
12.4.3 By Type
12.5 Spain Compounding Pharmacies Market Trend And Forecast Analysis: Segmentation
12.5.1 By Therapeutic Area
12.5.2 By End Users
12.5.3 By Type
12.6 Russia Compounding Pharmacies Market Trend And Forecast Analysis: Segmentation
12.6.1 By Therapeutic Area
12.6.2 By End Users
12.6.3 By Type
12.7 Turkey Compounding Pharmacies Market Trend And Forecast Analysis: Segmentation
12.7.1 By Therapeutic Area
12.7.2 By End Users
12.7.3 By Type
12.8 Benelux Compounding Pharmacies Market Trend And Forecast Analysis: Segmentation
12.8.1 By Therapeutic Area
12.8.2 By End Users
12.8.3 By Type
12.9 Nordic Compounding Pharmacies Market Trend And Forecast Analysis: Segmentation
12.9.1 By Therapeutic Area
12.9.2 By End Users
12.9.3 By Type
12.10 Rest of Europe Compounding Pharmacies Market Trend And Forecast Analysis: Segmentation
12.10.1 By Therapeutic Area
12.10.2 By End Users
12.10.3 By Type
13. Competitive Positioning
13.1 Companies' Product Positioning
13.2 Market Position Matrix
13.3 Market Share Analysis of Compounding Pharmacies Market
13.4 Company Profiles
13.4.1 Athenex
13.4.2 Baxter International
13.4.3 Fagron
13.4.4 Grifols
13.4.5 Capsa Healthcare
13.4.6 Nephron Pharmaceuticals
13.4.7 B. Braun
13.4.8 Fresenius
13.4.9 McKesson
13.4.10 Omnicell
Industrial protective clothing constitutes specialized attire fabricated from engineered textiles intended to safeguard personnel operating amid potentially perilous occupational environments from exposure to myriad hazards inherent to industrial settings such as manufacturing plants, construction s...
A compounding pharmacy specializes in the bespoke formulation of pharmaceutical products tailored to the unique requirements of individual patients, often creating medications that are not commercially available. This practice involves the modification or combination of ingredients to produce custom...
Europe cutting tools market was valued at $6.85 billion in 2023 and will grow by 4.6% annually over 2023-2033. The growth is driven by the increasing production and manufacturing activities, improved operational efficiency and innovative design, and an increasing demand for power tools for DIY activ...
Europe paper machine clothing (PMC) market was valued at $ 631.1 million in 2023 and will grow by 3.6% annually over 2023-2033. The growth is driven by the increasing demand for paper and paper-based products across various industries, technological advancements in the papermaking process, the intro...
Europe endoscopy devices market was valued at $10.1 billion in 2023 and will grow by 5.9% annually over 2023-2033. The growth is driven by the increasing prevalence of chronic diseases, the growing demand for less invasive procedures, a rising adoption of disposable endoscopic components, growing ge...
Europe digital health and wellness market was valued at $100.9 billion in 2023 and will grow by 18.9% annually over 2023-2033. The growth is driven by an increasing number of chronic diseases, the growing investment in health and wellness programs, the increased use of smartphones and wearable devic...
Europe connected healthcare device market was valued at $16 billion in 2023 and will grow by 19.2% annually over 2023-2033. The growth is driven by the emergence of telehealth and telemedicine services, benefits such as reliability and effective patient monitoring, the penetration of mobile and inte...
Europe bioprocess technology market was valued at $6.56 billion in 2023 and will grow by 13.7% annually over 2023-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology sector, ongoing tech...
Europe biopharmaceuticals market was valued at $116.5 billion in 2023 and will grow by 8.6% annually over 2023-2033, driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discovery, growing clinical t...
Europe encoder market was valued at $ 727.2 million in 2023 and will grow by 8.1% annually over 2023-2033. The growth is driven by the increased need for high-level automation across various industries, the surging demand for automobile and consumer electronics, and technological advancements....